ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 160 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2021. The put-call ratio across all filers is 3.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $579,390 | -7.1% | 93,000 | 0.0% | 0.01% | +25.0% |
| Q3 2022 | $624,000 | +5.4% | 93,000 | 0.0% | 0.01% | +33.3% |
| Q2 2022 | $592,000 | +37.0% | 93,000 | 0.0% | 0.01% | +50.0% |
| Q1 2022 | $432,000 | -7.3% | 93,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $466,000 | -95.0% | 93,000 | -74.1% | 0.00% | -90.0% |
| Q4 2020 | $9,328,000 | -30.1% | 358,800 | 0.0% | 0.04% | -52.4% |
| Q3 2020 | $13,336,000 | -2.5% | 358,800 | +34.6% | 0.08% | -27.6% |
| Q2 2020 | $13,680,000 | +158.2% | 266,600 | +123.3% | 0.12% | +314.3% |
| Q3 2018 | $5,298,000 | +13.2% | 119,400 | 0.0% | 0.03% | +27.3% |
| Q2 2018 | $4,680,000 | – | 119,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |